Strain-specific and dose-dependent clinical efficacy of probiotics on bone mineral density improvement in postmenopausal women: a meta-analysis based on RCT studies.

Authors

Lu Liu, Jing Liu, Yi Zhu, Chongxiao Liu

Published in

Nutrition & metabolism. Volume 23. Issue 1. Sep 11, 2026. Epub Sep 11, 2026.

Abstract

Probiotics may provide a safe and feasible alternative or adjuvant strategy for osteoporosis. However, there is no consensus on its strain specificity, dose threshold, and site differences. This meta-analysis quantitatively evaluates the strain-specific and dose-dependent clinical efficacy of probiotics on bone mineral density (BMD) in postmenopausal women.
Systematically search PubMed, Embase, Web of Science Core Collection, Scopus, Cochrane, and ClinicalTrials.gov up to December 24, 2025. Randomized controlled trials (RCTs) of probiotic/synbiotic interventions in postmenopausal women were included. A fixed-effects model was used to pool the standardized mean differences (SMD). Subgroup analyses were conducted based on probiotic genus (with Lactobacillus vs. without Lactobacillus), strain number (single vs. multi-strain), dose (≥ 1 × 10¹⁰ vs. <1 × 10¹⁰ CFU/d), and intervention duration.
A total of 11 RCTs (12 reports, n = 1388) were entered into the analysis. Overall change in BMD was not significant (SMD = 0.01, 95% CI = -0.06, 0.08, I² = 0%). Lumber spine BMD was significantly higher in Lactobacillus subgroup (SMD = 0.19, 95% CI = 0.01, 0.37). Lactobacillus showed negative trends in hip (SMD = -0.07) and femur (SMD = -0.08) BMD. Exploratory analyses suggested a potential dose-response plateau at 1 × 10⁹-7.5 × 10⁹ CFU/d. Prolonged interventions (> 6 months) or higher dose did not increase lumbar gains and conversely turned the hip/femur effect negative. Safety profile did not differ from placebo. Based on the GRADE framework, evidence was moderate for lumbar spine BMD and adverse events but low for hip and femur BMD. This means research is needed to refine these estimates.
Effect of probiotics on BMD in postmenopausal women is site-genus-dose dependent. A single Lactobacillus strain at 1 × 10⁹-7.5 × 10⁹ CFU/d for 3-6 months is recommended for lumbar spine protection.
Not applicable.

PMID:
42919406
Bibliographic data and abstract were imported from PubMed on 24 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.